Institutional investors purchased a net $1.9 million shares of DXCM during the quarter ended March 2017 and now own 108.81% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SLATE PATH CAPITAL LP Bought 1.1 Million shares of DexCom Inc
THE BOSTON COMPANY ASSET MANAGEM... Bought 1.0 Million shares of DexCom Inc